High-dose insulin infusion in patients with COVID-19

To the editor, The SARS-CoV-2, which causes COVID-19, has resulted in over 100 million cases of infection and more than 2 million deaths globally, as of February 2021. Diabetes and uncontrolled hyperglycemia are risk factors for poor outcomes in patients with COVID-19 including increased risk of severe illness or death.1 One observational study described glycemic and clinical outcomes in 1122 patients with and without diabetes and/or acute...